Schimpff Sc
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
- Oncology top 10%
- Neutropenia and Cancer Infections
Papers in
- Oncology 5
- Neutropenia and Cancer Infections 5
-
- Fungal Infections and Studies 2
- Multiple and Secondary Primary Cancers 1
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- Young Rc (1 shared paper)Graw Rg (1 shared paper)Levine As (1 shared paper)Joseph Aisner (1 shared paper)Pizzo Pa (1 shared paper)Wiernik Ph (6 shared papers)
- Journals
- PubMed (11 papers)
In The Last Decade
Schimpff Sc
11 papers receiving 262 citations
Peers
Comparison fields: 5 of 58
- Clinical Biochemistry 68
- Oncology 227
- Molecular Medicine 40
- Emergency Medicine 63
- Infectious Diseases 74
Countries citing papers authored by Schimpff Sc
This map shows the geographic impact of Schimpff Sc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schimpff Sc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schimpff Sc more than expected).
Fields of papers citing papers by Schimpff Sc
This network shows the impact of papers produced by Schimpff Sc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schimpff Sc. The network helps show where Schimpff Sc may publish in the future.
Co-authors
The 6 scholars most cited alongside Schimpff Sc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. | 1974 | 234 |
| 2 | Empiric antibiotic therapy. | 1978 | 40 |
| 3 | Strategies for the prevention of infection in the myelosuppressed or immunosuppressed cancer patient. | 1983 | 31 |
| 4 | Empiric antibiotic therapy for granulocytopenic patients. | 1982 | 15 |
| 5 | A comparative trial of tobramycin vs gentamicin in combination with vancomycin and nystatin for alimentary tract suppression in leukemic patients. | 1979 | 11 |
| 6 | Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin. | 1977 | 9 |
| 7 | Evaluation of radiotherapay for localized inflammatory skin and perianal lesions in adult leukemia: A porspectively randomized double blind study. | 1977 | 6 |
| 8 | In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients. | 1979 | 3 |
| 9 | Dual lumen catheters for angioaccess in patients with leukemia. | 1983 | 3 |
| 10 | Rifampin and cloxacillin in the reduction of Staphylococcus aureus colonization. | 1983 | 1 |
| 11 | Schimpff tells prevention strategies. | 1978 | 1 |
About Schimpff Sc
Schimpff Sc is a scholar working on Oncology, Epidemiology, Molecular Biology, Pharmacology and Dermatology, having authored 11 papers that have together received 354 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (5 papers), Fungal Infections and Studies (2 papers), Chemotherapy-related skin toxicity (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Hematological disorders and diagnostics (2 papers), Multiple and Secondary Primary Cancers (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Clinical Biochemistry (68 citations), Oncology (227 citations), Molecular Medicine (40 citations), Emergency Medicine (63 citations) and Infectious Diseases (74 citations). Frequent co-authors include Young Rc, Graw Rg, Levine As, Joseph Aisner, Pizzo Pa and Wiernik Ph. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.